Evidence map›Paper›PMID 39400133›Full record

ArticleJournal of visualized experiments : JoVE2024

Determining the Serum Stability of Human Adenosine Deaminase 1 Enzyme.

Yusef Haikal, Maria Rain Jennings, Johnathan Nguyen, John J Blazeck

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yusef HaikalSchool of Chemical and Biomolecular Engineering, Georgia Institute of Technology.
Maria Rain JenningsJohns Hopkins University School of Medicine.
Johnathan NguyenSchool of Chemical and Biomolecular Engineering, Georgia Institute of Technology.
John J BlazeckSchool of Chemical and Biomolecular Engineering, Georgia Institute of Technology; john.blazeck@chbe.gatech.edu.

Funding

Synthetic metabolism to armor and enhance a new class of cell therapiesDP2CA280622 · NCI · GEORGIA INSTITUTE OF TECHNOLOGY · PI BLAZECK, JOHN JAMES · 2022 to 2025
$2.3M
NCI NIH HHS DP2 CA280622
6 · The paper itself

Abstract

The concept of enzyme stability is typically used to refer to an enzyme's thermostability - its ability to retain structure and activity as temperature increases. For a therapeutic enzyme, other measures of stability may also be critical, particularly its ability to retain function in human serum at 37 °C, which we refer to as serum stability. Here, we describe an in vitro assay to assess the serum stability of the wildtype Homo sapiens adenosine deaminase I (HsADA1) enzyme using an absorbance-based microplate procedure. Specifically, this manuscript describes the preparation of buffers and reagents, a method arranging for the coincubation of HsADA1 in serum, a method to analyze the test samples using a microplate reader, and an accompanying analysis to determine the fraction of activity that an HsADA1 enzyme retains in serum as a function of time. We further discuss considerations to adapt this protocol to other enzymes, using an example of a Homo sapiens kynureninase enzyme, to help aid the protocol's adaptation to other enzymes where serum stability is of interest.

Indexed as

Adenosine DeaminaseEnzyme StabilityHumansSerumADA protein, humanAdenosine Deaminase

Identifiers

PMID39400133
PMCPMC12535683

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.